PEMETREXED DIPOTASSIUM
NDC 83831-111, pemetrexed dipotassium, injection, powder, lyophilized, for solution, from Avyxa Pharma, LLC.
- Product NDC
- 83831-111
- Status
- Listed
- Labeler
- Avyxa Pharma, LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA210661
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83831-111 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PEMETREXED100 mg/4mL
Pharmacologic classes
Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83831-111-01 | 83831011101 | 1 VIAL in 1 CARTON (83831-111-01) / 4 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/adc9ce4c-926a-4ee8-bd0d-d06fc89c17fc
Use it
Look up 83831-111 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83831-111 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83831-111. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.